BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Esperance Pharmaceuticals, Inc. Presents Results From Phase 1 Study of EP-100 in Advanced, Refractory LHRH-Receptor Expressing Solid Tumors at American Society of Clinical Oncology

  June 4, 2012

   · 

  4 min read
• Biotech Bay

  CytRx Corporation to Hold Conference Call Today at 10:00 a.m. Eastern Time to Discuss Favorable Results from INNO-206 Clinical Trial in Soft Tissue Sarcoma

  June 4, 2012

   · 

  1 min read
• Drug Development

  Millennium: The Takeda Oncology Company Release: Clinical Data Presented on Orteronel (TAK-700) Without Steroids in Non-Metastatic Prostate Cancer

  June 4, 2012

   · 

  1 min read
• Drug Development

  Synta Pharmaceuticals Announces Ganetespib Presentations at the Annual Meeting of the American Society of Clinical Oncology

  June 4, 2012

   · 

  1 min read
• BioMidwest

  Ventria Bioscience’s InVitria Division Awarded 2-Year, $1.5 Million Grant to Develop Superior System for Cell-Based Vaccine Production

  June 4, 2012

   · 

  1 min read
• Business

  Mayo Medical Laboratories and Atherotech Diagnostics Lab to Offer Critical Diagnostics’ ST2 Test

  June 4, 2012

   · 

  1 min read
• BioMidwest

  American Society of Clinical Oncology Presentations Highlight Clinical Utility of Caris Life SciencesTarget Now™ in Molecular Profiling of Breast and Head and Neck Cancers

  June 4, 2012

   · 

  6 min read
• Drug Development

  Updated Analysis of Phase III ALSYMPCA Study for Bayer HealthCarer’s Investigational Compound Radium-223 Dichloride to be Presented at the 48th Annual American Society of Clinical Oncology Meeting

  June 4, 2012

   · 

  6 min read
• Drug Development

  Active Biotech AB’s and Ipsen’s Tasquinimod Shows Encouraging Overall Survival Improvement in Castrate Resistant Prostate Cancer

  June 4, 2012

   · 

  1 min read
• Drug Development

  OncoGenex Pharmaceuticals Inc. Release: Data from a Phase 2 Study Presented at the 2012 American Society of Clinical Oncology Annual Meeting Continues to Show Early Activity of OGX-427 in Patients with Prostate Cancer

  June 4, 2012

   · 

  5 min read